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Abstract 
Mitochondrial function in muscle in vivo can be quantitatively evaluated using 31-phosphorus nuclear magnetic resonance. In resting 
muscle, the concentrations of ions (e.g. H ÷, Na ÷) and two of the major bioenergetic components (inorganic phosphate and creatine) are 
determined by regulated transcellular t ansport processes. During recovery after exercise the kinetics and control of mitochondrial ATP 
synthesis can be established. During exercise the relative contributions to ATP synthesis of phosphocreatine (using creatine kinase), 
anaerobic glycogenolysis and oxidative phosphorylation are dissected and have been shown to change with time. The consequences of 
mitochondrial lesions and dysfunctions on these processes have been summarised. 
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1. Introduction 
The relationship between contractility of muscle and 
cellular bioenergetics an be considered at three stages: 
At rest, the cellular homeostasis of bioenergetic compo- 
nents (e.g. total creatine, adenine nucleotides) is deter- 
mined by hormonally controlled transport processes. The 
concentrations of key ions are also fixed in the resting cell. 
During exercise, control of blood flow and of oxidative 
ATP synthesis are to some extent linked. The regulation of 
glycogenolysis, when oxidative metabolism is inadequate, 
and that of fuel selection are also centred on energetics 
during exercise. 
In the recovery phase, glycogenolysis  shut down and 
the process, at least in normal situations, is entirely oxida- 
tive. At the same time, waste products (largely H ÷ and 
lactate) must be cleared from the muscle cells. 
The basic bioenergetic processes as described in text- 
books are centred around the generation of ATP by oxida- 
tive phosphorylation, anaerobic glycogenolysis and the 
conversion of phosphocreatine (PCr) by creatine kinase. It 
is notable that H ÷ ions play a role in these processes, 
being part of the creatine kinase reaction and of lactic acid 
(lactate + H ÷) production. 
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It is now well established that phosphorus nuclear mag- 
netic resonance (31 P-NMR) can be used to measure quanti- 
tatively and non-invasively the concentrations of some of 
the major phosphate-containing metabolites (ATP, PCr, Pi, 
hexose-phosphates) and of H ÷ (strictly the cytosolic pH) 
in skeletal muscle at rest, during exercise and in recovery 
[1]. The time resolution of the measurement (depending on 
the muscle group being examined), is between 1 sec and 1 
minute. The two most commonly studied human muscles 
are the flexor digitorum superficialis (involved in finger 
flexion) and the gastrocnemius, which is stressed by plan- 
tar flexion. Well worked-out protocols are now available to 
follow time-courses of bioenergetic changes in human and 
animal muscle. 
2. Results and discussion 
2.1. Setting resting concentrations 
The processes that are important in determining the 
cellular concentrations of substances involved in the basic 
bioenergetic reaction and some of the other energetic 
parameters are summarised in Table 1. 
Inorganic phosphate (Pi) is derived from the blood and 
is a determining factor in setting the total phosphorus level 
in the cell. Pi transport is Na ÷ dependent [2,3] with a 
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Table 1 
A list of processes that are involved in determining the resting concentra- 
tions of ions and phosphorus containing bioenergetic components 
Processes involved in setting resting concentrations 
Pi and total phosphorus by Pi transport 
total creatine by creatine transport 
H +, Na 2+, Ca 2+ by ion pumps and channels 
ADP by creatine kinase equilibrium 
phosphorylation potential by mitochondria 
stoichiometry of two Na + ions taken up with for one Pi. 
The steady-state intracellular P~ concentrations are deter- 
mined by the rate of Na+/Pi entry, counteracted by pas- 
sive Pi efflux. Pi entry is under hormonal control as is 
shown in Fig. 1. Insulin and insulin-like growth factors 
(IGF) stimulate the rate of Pi uptake in G-8 cells and in 
isolated soleus muscle. The mechanisms of the enhance- 
ment of P~ uptake by the two substances are different, in 
that IGF stimulation is delayed in comparison to insulin 
activation and is inhibited by dicyclohexylcarbodiimide 
(DCCD). This suggests that the effect of IGF requires new 
protein synthesis, unlike in the case of the insulin effect. 
The relationship between extracellular (blood) Pi and 
intracellular muscle Pi is shown in Fig. 2. This study is 
based on a group of patients in renal failure who have high 
plasma phosphate concentrations [4]. In control subjects 
both extra- and intracellular P~ is maintained within narrow 
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Fig. 1. Time-course of the effects of insulin and IGF-1 on Pi influx in G8 
cells. The figure shows the onset of stimulation by (a) 10000 izU/ml 
insulin and (c) 720 nM IGF- 1 as a function of exposure time. Horizontal 
line shows the control value at t = 0. Incubations performed in 120 mM 
sodium (all n = 6). 
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Fig. 2. The effect of alteration in plasma [Pi] on cell P i /ATP in 
undialysed uraemic patients. A significant linear correlation was observed 
( r=0.5 ,  P<0.01) .  The mean cell P i /ATP (±S.E.M.) for 10 age- 
matched control subjects is indicated by the boxed area. 
limits. In the patient group intracellular Pi increases lin- 
early with blood Pi. Importantly, in spite of the increase in 
intracellular P~, the phosphorylation potential remains con- 
stant. The reciprocal phosphorylation potential in controls 
is 4.5 _+ 0.7 and in patients 4.9 _+ 0.1 (M • 10-6) .  Creatine 
kinase plays a role in ensuring constancy in the phospho- 
rylation potential, since an increase in cellular Pi, is ac- 
companied by an increase in PCr, and a decrease in ADP. 
This effect can be illustrated better in the perfused heart 
[5]. P~ withdrawal from the perfusate results in a decrease 
in cellular P~ and PCr and these changes are reversed by 
reperfusing with phosphate-containing buffer. Throughout 
this manipulation, however, phosphorylation potential re- 
mains constant. The same is true in the presence of insulin, 
except hat the phosphorylation potential is set at a higher 
value and is maintained at this high value with + P~ in the 
external medium. Why insulin improves phosphorylation 
potential is not well understood, but it may be a result of 
improved substrate (e.g. glucose) delivery. 
Relatively little is known about the regulation of the 
cellular content of total creatine (PCr + creatine) which is 
a fundamental bioenergetic parameter. A sodium creatine 
cotransporter that is responsible for creatine uptake has 
been described in several cell lines [6]. We investigated 
creatine transport and accumulation i a cultured G8 my- 
oblast line [7]. Creatine uptake is rapid, saturable and 
sodium-dependent. Total cellular creatine concentration is 
relatively independent of extracellular c eatine levels. This 
is consistent with a high affinity active uptake balanced by 
slow passive effiux. The kinetic characteristics of the 
transporter in the G8 cells are similar to those in human 
muscle, suggesting that creatine homeostasis n muscle is 
likely to be modulated by factors similar to those we 
demonstrated in the G8 cell. Among these we found that 
net creatine uptake is stimulated by isoproterenol, nor- 
adrenaline and the cAMP analogue N6,2'-O-dibutyryla - 
denosine Y:5'-cyclic monophosphate, but not by the cq 
adrenergic receptor agonist methoxamine. 
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Fig. 3. A schematic diagram representing creatine transport and its 
relation to the Na + + K+-ATPase. 
Net creatine uptake is also increased by 3,3'5-tri- 
iodothyronine and by amylin; both these factors (and 
isoproterenol) are known or believed to stimulate the 
Na+,K+-ATPase. Further studies with /3 receptor agonists 
and antagonists showed the importance of the /32 receptor 
in the control of active creatine uptake, and the role of the 
Na+,K + ATPase according to the model shown in Fig. 3, 
which explains the relationship between creatine influx, 
effiux and the Na+,K+-ATPase. 
There is considerable interest in the possible benefits to 
skeletal muscle function of dietary creatine supplementa- 
tion which increases both muscle creatine content and 
maximal voluntary muscle contraction [8]. Our results 
suggest hat creatine supplementation should be particu- 
larly beneficial when coupled to a training regimen. 
2.2. -~IP-NMR of resting muscle in mitochondrial disease 
We examined skeletal muscle in 29 patients with mito- 
chondrial myopathy using 31p_NMR [9]. In 86% of pa- 
tients (25/29) abnormalities were detected in resting mus- 
cle. In most cases there was a low PCr/ATP ratio, high 
calculated free [ADP] and low phosphorylation potential. 
At rest, abnormality was detected with equal ease in the 
finger flexor muscle (flexor digitorum superficialis:fds) 
and gastrocnemius. In fds phosphorylation potential was 
the best discriminator f abnormality, while, in spite of a 
significantly increased mean P~/ATP, this ratio was not a 
good discrimination i most patients. The metabolic abnor- 
malities in this condition are better understood uring 
exercise and recovery (see below). 
2.3. Metabolic recot,e~ following exercise 
The quantitative analysis of recovery data unlike that 
during exercise is simplified by the facts that muscle mass 
and the nature and severity of exercise do not influence the 
metabolic hanges directly. At the end of exercise glyco- 
genolysis is switched off so that the rate of PCr recovery 
provides a measure for mitochondrial ATP synthesis. The 
other major processes are involved in the removal of the 
products of exercise (H +, lactate). The kinetic analysis of 
PCr and pH recovery, is therefore of major importance for 
our understanding of the mechanisms of recovery in nor- 
mal and diseased states. The initial rate of PCr recovery 
after exercise has a hyperbolic relationship to the end 
exercise cytosolic ADP concentration [10] as does the rate 
of PCr synthesis throughout recovery to the ADP concen- 
trations during the recovery period. The near-equilibrium 
process catalysed by creatine kinase ensures that PCr, ADP 
and intracellular pH are related by the expression - [ADP] 
= {([total Cr]/[PCr])-l} [ATP]/K[H +] where K is the 
equilibrium constant (1.66. 10 9 1/mol) for the creatine 
kinase reaction. The relationship between the rate of mito- 
chondrial ATP synthesis (Q measured in mmol per min) 
and cytosolic ADP: 
Q = Qmax/(1 + Km/[ADP]) can be used to calculate Q 
at half maximal [ADP], giving K m (30 /zmol/1 cell water) 
and the maximum value (Qm~x) (40 mmol/l cell water per 
min). The pH variations are thus allowed for in the calcula- 
tion of free cytosolic ADP although low pH may also have 
a direct effect on the mitochondrial ATP-synthase. Thus 
ADP can be taken as the error signal for ATP control. If 
ATP usage transiently exceeds ATP synthesis by 
XmM/min, PCr falls at XmM/min so ADP rises until 
ATP synthesis rate matches usage. From the creatine ki- 
nase equilibrium expression the relative change in ADP 
exceeds that in PCr by [total Creatine/Cr-2.3 PCr 
(dpH/dPCr)] = 10 at rest. 
In mitochondrial myopathy in our study nearly all pa- 
tients (25/27, 93%) showed abnormalities during recovery 
from exercise [9]. The major features are slow pbospho- 
creatine recovery, increased pH recovery rates and as a 
result of this high cytosolic free [ADP]. The up-regulation 
of the H + clearance results in an increase in ADP that in 
part can compensate for the decreased mitochondrial ca- 
pacity (Qmax) by allowing the less well functioning mito- 
chondria to operate closer to their maximal activities. 
2.4. Bioenergetic hanges during exercise 
The quantitative evaluation of the bioenergetic parame- 
ters during exercise is somewhat more complex as the 
increased emand for ATP hydrolysis is met by three 
processes: glycogenolytic (anaerobic) ATP synthesis, ox- 
idative ATP synthesis and the conversion of PCr to ATP. 
The latter is directly measured while the contributions 
from the former two (and their rates) can be estimated, 
provided the rate of lactate production can be measured. 
This is done by measuring cytosolic pH from which lactate 
production can be calculated if we know the passive 
buffering capacity of the cell and the rate of proton 
18 G.K. Radda et al. / Biochimica et Biophysica Acta 1271 (1995) 15-19 
Table 2 
List of disease conditions studied where mitochondrial abnormalities may be present 
Disease groups by mitochondrial function 
Group A: 
low Qmax high ADP 
mitochondrial myopathy 
peripheral ischaemia 
uraemia on dialysis 
Group C: 
normal Qmax high ADP (fast H+/Na +) 
hypertension 
myotonic dystrophy 
duchenne carriers 
Group B: 
low Qmax normal ADP (large pH change) 
cardiac failure 
cyanotic heart disease 
myeloidysplastic anaemia 
Group D: 
normal Qmax and ADP (acidosis) 
iron deficiency 
respiratory failure 
12C 79 treatment 
removal. This last parameter can be measured during 
recovery. From this H ÷ removal during exercise can be 
calculated if we assume that the same pH dependence for 
H + effiux applies during exercise as has been demon- 
strated uring the recovery phase. 
We can dissect he various contributions to ATP synthe- 
sis during exercise by comparing the changes observed 
under ischaemic and aerobic conditions at the same muscle 
performance. We have carried out such a study on the 
flexor digitorum superficialis in four adult males during 
dynamic ischaemic and aerobic exercise at three different 
work rates and during recovery from aerobic exercise [11]. 
During exercise, changes in pH and PCr were larger at 
higher power, but in aerobic exercise neither end-exercise 
[ADP] nor the initial post-exercise PCr resynthesis rate 
altered with power. In ischaemic exercise we estimated 
total ATP resynthesis from the rates of PCr depletion and 
glycogenolysis nferred using an analysis of proton buffer- 
ing. The estimate of total ATP turnover emained constant 
with time and was shown to be proportional to work rate. 
As PCr decreased, the relative contribution from glyco- 
genolysis to ATP synthesis increased in parallel so as to 
maintain the total ATP synthesis rate. Comparison of the 
calculated ATP turnover in ischaemic and aerobic exercise 
suggested that oxidative ATP synthesis was small during 
the first minute of aerobic exercise and increased with a 
half-time of around 0.5-1 rain. This suggests that oxida- 
tive ATP synthesis is negligible during the first half-minute 
of aerobic exercise at mechanical power output levels of 
0.5, 0.67 and 1 W. Using the values of proton efflux 
derived from studying pH recovery after exercise, we 
could estimate ATP synthesis by glycogenotysis during 
aerobic exercise from the measured pH changes. The Pi 
concentration has a significant effect on the rate of glyco- 
genolysis and this may be of regulatory significance as Pi 
is a substrate for glycogen phosphorylase and an activator 
of phosphofructokinase. 
We can measure haemoglobin desaturation during aero- 
bic and ischaemic exercise by infra-red spectroscopy. At 
0.5 W haemoglobin desaturation was higher at the end of 
the first minute of aerobic exercise (in fact as high as 
during ischaemic exercise) than at the end of exercise. This 
mirrors the calculated rate of oxidative ATP synthesis. A 
possible xplanation is a delayed increase in blood flow so 
that oxidative ATP synthesis is limited first by the rate of 
arterial oxygen supply and then, at later stages, by the 
cytosolic ADP concentration when oxygen supply is ade- 
quate. 
Analysis of  PCr recovery kinetics in human diseases with 
possible mitochondrial dysfunction 
From the hyperbolic relationship between PCr recovery 
and cytosolic ADP concentrations, we estimated the appar- 
ent maximum rate of ATP synthesis (Qmax) in a variety of 
human disease states where mitochondrial function may be 
impaired [12]. We identified four patterns: (A) In mito- 
chondrial myopathy, apparent Qmax is reduced relative to 
controls, and as already described, [ADP] is increased to 
stimulate PCr resynthesis at a rate as near as possible to 
normal. This occurs despite increased lactic acid produc- 
tion, because proton effiux is upregulated. (B) In some 
conditions (e.g. cyanotic ongenital heart disease) apparent 
Qmax is reduced without compensatory rise in ADP. In 
these cases the contribution of anaerobic ATP synthesis 
during exercise is increased and leads to a large pH change 
and little rise in ADP. (C) In the third group of conditions 
(e.g. myotonic dystrophy) ADP is increased uring exer- 
cise but apparent Qmax is normal, suggesting an abnormal 
increase in proton effiux and/or decrease in anaerobic 
glycogenolysis during exercise. (D) Finally, there are con- 
ditions (e.g. respiratory failure) where, despite impaired 
substrate supply, both apparent Qmax and end-exercise 
ADP are normal. Some of the conditions studied are 
summarised in Table 2. This kind of analysis may be 
useful in characterising different diseases where mitochon- 
drial dysfunction is suspected. In particular adaptive 
changes to chronic conditions may be distinguished from 
the results of acute responses to impaired oxidative 
metabolism. 
3. Conclusions 
The functional consequences of mitochondrial disease 
are not always immediately evident. This is in part, be- 
cause there are various compensatory mechanisms that are 
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available and in part because there is substantial mitochon- 
drial reserve in most organs of the body. It is possible that 
as a result of the large energetic dynamic range required in 
skeletal muscle function, mitochondrial dysfunction is most 
readily detected in muscle. 31P-NMR provides a sensitive 
and quantif iable test for this functional defect. 
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